Senior Director, Market Access Berkeley Heights, NJ

Tonix is a fully integrated biotechnology company, publicly traded on NASDAQ (ticker: TNXP), with marketed products and a pipeline of development candidates The Company is focused on commercializing, developing, discovering, and licensing therapeutics to treat and prevent human disease. In August 2025, Tonix received FDA approval for Tonmya™ (cyclobenzaprine HCl sublingual tablets), a first-in-class, once-daily, non-opioid treatment for fibromyalgia. Tonmya is the first new fibromyalgia therapy approved in over 15 years, following successful Phase 3 trials demonstrating significant symptom improvement.

Commercial launch is expected in the fourth quarter of 2025. Tonix also markets Zembrace® Sym Touch® (sumatriptan injection) 3 mg and Tosymra® (sumatriptan nasal spray) 10 mg, both indicated for the treatment of acute migraine with or without aura in adults.

Tonix’s development portfolio includes product candidates in central nervous system (CNS), immunology, immuno-oncology infectious disease and rare disease. The CNS pipeline features both small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer. The infectious disease pipeline includes a vaccine in development to prevent smallpox and monkeypox, which also serves as a live virus vaccine platform for other infectious diseases.

Finally, therare disease portfolio includes a product in development for Prader‑Willi syndrome, which has both orphan drug designation and rare pediatric disease designation grants from the FDA.

Tonix owns and operates a state‑of‑the‑art infectious disease research facility in Frederick, Md.

Please visit  for specifics on the pipeline.

* All of Tonix’s product candidates are investigational new drugs or biologics and have not been approved for any indication.

Position Overview

The Senior Director, Access Marketing and Patient Support Services plays a pivotal role in ensuring patient access to Tonix Pharmaceuticals therapies, leading strategic initiatives, collaborating with cross‑functional teams, and driving patient‑centric programs, directly impacting patient outcomes and contributing to the success of our organization. This role is responsible for collaborating with the brand team, NADs and MSLs to develop and execute on GPO/Payer strategies, national account‑specific strategies, and other associated targets.

This position in collaboration with our designated PSS vendor(s) will ensure the efficient design, and execution of access services (HUBs, CoPay and other financial support services) resulting in a positive provider and patient experience that optimizes script “pull‑through”.

• Lead the development of market access strategy across all market access segments and execution plan

• Build a value proposition by articulating the business strategy and economic choices for each stakeholder.

• Responsible for building access and patient support program awareness, perception, and proficiency with HCPs through field teams (Sales and Field Access)

• Work across the patient support and cross‑functional teams to integrate patient services strategy into Tonix’s broader market access strategy to optimize patient access post‑approval

• Monitor, troubleshoot and proactively develop plans of action for issues throughout the patient journey

• Synthesize data/analytics by partnering with our PSS partners and Comm Ops to effectively evaluate the entire HCP and patient journey

• Own all customer‑facing materials and communications for market access teams (Payers, IDNs, PBMs)

• Partner closely with Brand Marketing, National Accounts, Field Access, MSLs and Patient Services teams to lead and develop compliant customer specific initiatives that drive greater product and patient outcomes.

• Determine appropriate action, execution, tracking and monitoring of projects by employing scenario planning, segmentation, positioning, innovation, creative development, and investment optimization as needed.

• Establish payer engagement plans with the Market Access team to support payer education, facilitate access…